Ptc Therapeutics (PTCT) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to 0.06.
- Ptc Therapeutics' Equity Ratio rose 8970.57% to 0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06, marking a year-over-year increase of 8970.57%. This contributed to the annual value of 0.64 for FY2024, which is 4914.93% down from last year.
- According to the latest figures from Q3 2025, Ptc Therapeutics' Equity Ratio is 0.06, which was up 8970.57% from 0.08 recorded in Q2 2025.
- Ptc Therapeutics' 5-year Equity Ratio high stood at 0.14 for Q1 2021, and its period low was 0.64 during Q4 2024.
- In the last 5 years, Ptc Therapeutics' Equity Ratio had a median value of 0.14 in 2022 and averaged 0.23.
- Its Equity Ratio has fluctuated over the past 5 years, first crashed by 2752600.22% in 2022, then surged by 8970.57% in 2025.
- Over the past 5 years, Ptc Therapeutics' Equity Ratio (Quarter) stood at 0.0 in 2021, then tumbled by 27526.0% to 0.2 in 2022, then tumbled by 112.19% to 0.43 in 2023, then tumbled by 49.15% to 0.64 in 2024, then soared by 90.85% to 0.06 in 2025.
- Its last three reported values are 0.06 in Q3 2025, 0.08 for Q2 2025, and 0.07 during Q1 2025.